TD Cowen Initiates SLGL Buy
TD Cowen initiates coverage of Sol Gel with a buy rating due to its dermatology drug. This may impact the stock's performance.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.